Literature DB >> 9577482

Unenhanced helical CT criteria to differentiate distal ureteral calculi from pelvic phleboliths.

T V Bell1, H M Fenlon, B D Davison, H K Ahari, S Hussain.   

Abstract

PURPOSE: To identify imaging features at unenhanced helical computed tomography (CT) that help differentiate distal ureteral calculi from pelvic phleboliths.
MATERIALS AND METHODS: Retrospective analysis was performed of 184 pelvic calcifications identified at unenhanced helical CT in 113 patients. The size, shape, and attenuation of each calcification were recorded in addition to the presence of a central lucency and the appearance of the adjacent soft tissues. With profile analysis, a graphic representation was generated of attenuation in each pixel along a line drawn through each calcification.
RESULTS: Geometric configuration was seen in eight (21%) calculi but not in any phleboliths. Differences were significant (P < .0001) between the mean attenuation of calculi and that of phleboliths. Among phleboliths, none had a mean attenuation greater than 278 HU, 13 (9%) had a visible central lucency, 31 (21%) had a bifid peak at profile analysis, 30 (21%) had the "comet sign" (adjacent eccentric, tapering soft-tissue mass corresponding to the noncalcified portion of a pelvic vein), and three (2%) had the soft-tissue rim sign (edema of the ureteral wall). Among calculi, none had a central lucency, bifid peak, or comet sign, but 29 (76%) had the soft-tissue rim sign.
CONCLUSION: Analysis of pelvic calcifications at unenhanced helical CT can help differentiate calculi from phleboliths.

Entities:  

Mesh:

Year:  1998        PMID: 9577482     DOI: 10.1148/radiology.207.2.9577482

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Distinguishing pelvic phleboliths from distal ureteral calculi: thin-slice CT findings.

Authors:  Mehmet Arac; Halil Celik; A Yusuf Oner; Serap Gultekin; Terman Gumus; Sule Kosar
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

Review 2.  [Imaging techniques and their impact in treatment management of patients with acute flank pain].

Authors:  A Grosse; C A Grosse; J Mauermann; G Heinz-Peer
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

3.  Increased urinary bladder volume improves the detectability of urinary stones at the ureterovesical junction in non-enhanced computed tomography (NECT).

Authors:  Maxim Avanesov; Julja Togmat; Mehtap Solmaz; Michael Gerhard Kaul; Azien Laqmani; Helena Guerreiro; Sarah Keller; Lars Weisbach; Gerhard Adam; Jin Yamamura
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

4.  Differentiation of urinary stone and vascular calcifications on non-contrast CT images: an initial experience using computer aided diagnosis.

Authors:  Hak Jong Lee; Kwang Gi Kim; Sung Il Hwang; Seung Hyup Kim; Seok-Soo Byun; Sang Eun Lee; Seong Kyu Hong; Jeong Yeon Cho; Chang Gyu Seong
Journal:  J Digit Imaging       Date:  2009-02-04       Impact factor: 4.056

5.  Differentiation of distal ureteral stones and pelvic phleboliths using a convolutional neural network.

Authors:  Johan Jendeberg; Per Thunberg; Mats Lidén
Journal:  Urolithiasis       Date:  2020-02-27       Impact factor: 3.436

Review 6.  Multidetector CT urography in imaging of the urinary tract in patients with hematuria.

Authors:  Michael M Maher; Mannudeep K Kalra; Stefania Rizzo; Peter R Mueller; Sanjay Saini
Journal:  Korean J Radiol       Date:  2004 Jan-Mar       Impact factor: 3.500

7.  Extraosseous accumulation of bone scan tracer (99m)Tc-methylene diphosphonate in a phlebolith.

Authors:  Mukta Kulkarni; Archi Agrawal; Anand Zade; Nilendu Purandare; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2012-01

8.  Low-Dose Unenhanced Computed Tomography with Iterative Reconstruction for Diagnosis of Ureter Stones.

Authors:  Byung Hoon Chi; In Ho Chang; Dong Hoon Lee; Sung Bin Park; Kyung Do Kim; Young Tae Moon; Taekyu Hur
Journal:  Yonsei Med J       Date:  2018-05       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.